Daiichi Sankyo Eliminates 280 U.S. Jobs

Daiichi Sankyo is eliminating approximately 280 U.S. jobs in a restructuring it said will better align its U.S. commercial operations with its current portfolio of marketed drugs and pipeline of cancer treatments.The 280 to be laid off are based at various locations in the U.S. The company bases its U.S. corporate headquarters in Basking Ridge, N.J., with two Daiichi Sankyo-owned companies also based stateside—Luitpold Pharmaceuticals, a Shirley, NY, manufacturer and marketer of pharmaceut